These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Pharmacological properties of acetorphan, a parenterally active "enkephalinase" inhibitor. Lecomte JM; Costentin J; Vlaiculescu A; Chaillet P; Marcais-Collado H; Llorens-Cortes C; Leboyer M; Schwartz JC J Pharmacol Exp Ther; 1986 Jun; 237(3):937-44. PubMed ID: 3519939 [TBL] [Abstract][Full Text] [Related]
24. Degradation of neurotensin by rat brain synaptic membranes: involvement of a thermolysin-like metalloendopeptidase (enkephalinase), angiotensin-converting enzyme, and other unidentified peptidases. Checler F; Vincent JP; Kitabgi P J Neurochem; 1983 Aug; 41(2):375-84. PubMed ID: 6308159 [TBL] [Abstract][Full Text] [Related]
25. Thiorphan and analogs: lack of correlation between potency to inhibit "enkephalinase A" in vitro and analgesic potency in vivo. Mendelsohn LG; Johnson BG; Scott WL; Frederickson RC J Pharmacol Exp Ther; 1985 Aug; 234(2):386-90. PubMed ID: 3894620 [TBL] [Abstract][Full Text] [Related]
26. Localization of the thiorphan-sensitive endopeptidase, termed enkephalinase A, on glial cells. Lentzen H; Palenker J FEBS Lett; 1983 Mar; 153(1):93-7. PubMed ID: 6337881 [TBL] [Abstract][Full Text] [Related]
27. Assessment of the role of "enkephalinase" in cholecystokinin inactivation. Zuzel KA; Rose C; Schwartz JC Neuroscience; 1985 May; 15(1):149-58. PubMed ID: 3892359 [TBL] [Abstract][Full Text] [Related]
28. Differences in the structural requirements for selective interaction with neutral metalloendopeptidase (enkephalinase) or angiotensin-converting enzyme. Molecular investigation by use of new thiol inhibitors. Fournie-Zaluski MC; Lucas E; Waksman G; Roques BP Eur J Biochem; 1984 Mar; 139(2):267-74. PubMed ID: 6321177 [TBL] [Abstract][Full Text] [Related]
29. Binding of the bidentate inhibitor [3H]HACBO-Gly to the rat brain neutral endopeptidase "enkephalinase". Waksman G; Bouboutou R; Devin J; Besselievre R; Fournie-Zaluski MC; Roques BP Biochem Biophys Res Commun; 1985 Aug; 131(1):262-8. PubMed ID: 3899113 [TBL] [Abstract][Full Text] [Related]
30. Pharmacological "enkephalinase" inhibition in man. Marcello F; Grazia SM; Sergio M; Federigo S Adv Exp Med Biol; 1986; 198 Pt B():153-60. PubMed ID: 3028074 [TBL] [Abstract][Full Text] [Related]
31. Effect of inhibitors of enkephalin degradation in the isolated guinea-pig ileum. van Amsterdam JG; van Buuren KJ; Krielaart MJ; Zuiderveld OP; Tijms RP Life Sci; 1988; 43(19):1529-36. PubMed ID: 3193845 [TBL] [Abstract][Full Text] [Related]
32. Enkephalin-degrading dipeptidylaminopeptidase: characterization of the active site and selective inhibition. Chérot P; Devin J; Fournié-Zaluski MC; Roques BP Mol Pharmacol; 1986 Oct; 30(4):338-44. PubMed ID: 3531805 [TBL] [Abstract][Full Text] [Related]
33. Enantiomers of thiorphan and acetorphan: correlation between enkephalinase inhibition, protection of endogenous enkephalins and behavioral effects. Giros B; Gros C; Schwartz JC; Danvy D; Plaquevent JC; Duhamel L; Duhamel P; Vlaiculescu A; Costentin J; Lecomte JM J Pharmacol Exp Ther; 1987 Nov; 243(2):666-73. PubMed ID: 3479550 [TBL] [Abstract][Full Text] [Related]
34. Multiple molecular forms of rat brain enkephalinase. Rush RS; Hersh LB Life Sci; 1982 Aug; 31(5):445-51. PubMed ID: 6813615 [TBL] [Abstract][Full Text] [Related]
35. Enkephalinase is involved in the degradation of endogenous substance P released from slices of rat substantia nigra. Mauborgne A; Bourgoin S; Benoliel JJ; Hirsch M; Berthier JL; Hamon M; Cesselin F J Pharmacol Exp Ther; 1987 Nov; 243(2):674-80. PubMed ID: 2445957 [TBL] [Abstract][Full Text] [Related]
36. New enkephalinase inhibitors as probes to differentiate "enkephalinase" and angiotensin-converting-enzyme active sites. Roques BP; Fournié-Zaluski MC; Florentin D; Waksman G; Sassi A; Chaillet P; Collado H; Costentin J Life Sci; 1982 Oct 18-25; 31(16-17):1749-52. PubMed ID: 6296575 [No Abstract] [Full Text] [Related]
37. Analgesic effects of kelatorphan, a new highly potent inhibitor of multiple enkephalin degrading enzymes. Fournie-Zaluski MC; Chaillet P; Bouboutou R; Coulaud A; Cherot P; Waksman G; Costentin J; Roques BP Eur J Pharmacol; 1984 Jul; 102(3-4):525-8. PubMed ID: 6386492 [TBL] [Abstract][Full Text] [Related]
39. In vitro and in vivo effects of kelatorphan on enkephalin metabolism in rodent brain. Waksman G; Bouboutou R; Devin J; Bourgoin S; Cesselin F; Hamon M; Fournie-Zaluski MC; Roques B Eur J Pharmacol; 1985 Nov; 117(2):233-43. PubMed ID: 3865779 [TBL] [Abstract][Full Text] [Related]
40. Carboxypeptidase activity in synaptic vesicles isolated from striatum and cortex of calf brain. Demmer W; Brand K Arch Biochem Biophys; 1985 Jun; 239(2):375-8. PubMed ID: 4004272 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]